FDA panel reviews 1st new Alzheimer's drug in 2 decades
by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca
Updated on: March 30,2024
18
FDA panel reviews 1st new Alzheimer's drug in 2 decades
by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca
Updated on:March 30,2024
18